{"id":"W2949395959","doi":"10.1136/annrheumdis-2019-eular.798","title":"FRI0452 TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DERMATOLOGIC ENDPOINTS FROM 2 PHASE 3 STUDIES","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Dermatology; Arthritis; Rheumatoid arthritis; Psoriasis; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Conference abstract reporting dermatologic endpoints of tofacitinib from two phase 3 trials; a clinical efficacy analysis."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"low","reason":"The title identifies a clinical treatment analysis, but the abstract is missing and provides insufficient detail."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Clinical phase-3 dermatologic endpoints for tofacitinib in psoriatic arthritis."}}}